Strive Health Inks $550M

Core Insights - Strive Health raised a total of $550 million through a Series D equity round of $300 million and $250 million in debt financing [1][2] Group 1: Funding Details - New Enterprise Associates (NEA) led the equity funding round, with additional investments from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Redpoint, and new institutional investors including BlackRock, Inc. [2] - Hercules Capital led the debt financing portion of the capital raise [2] Group 2: Company Overview - Strive Health is recognized as the national leader in value-based kidney care, partnering with innovative healthcare payors and providers [3] - The company utilizes AI technology, care interventions, and local provider integration to create an integrated care delivery system for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) [3] - Strive Health serves over 145,000 patients with CKD and ESKD across 50 states and collaborates with over 6,500 providers [3] - The company's case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST [3]